China
10.08.2020 | review
COVID-19: Extrapulmonary Manifestations
The disease damages the blood-forming organs, blood vessels, kidneys, liver, gastrointestinal tract, skin, endocrine and nervous systems
10.07.2020 | review
Type I interferons as a perspective treatment for COVID-19
Efficacy and safety of IFN-I in treating the new coronavirus
16.05.2020 | clinical research
China’s successful experience in preventing COVID-19 in non-infected medical stuff
None of the doctors at the Taihe hospital in Shiyan, Hubei province, got the virus within 28 days. 3-level protection: nasal interferon-α2b (4 times a day), thymosin-α1 once a week (subcutaneous)